ATE438383T1 - Verfahren zur herstellung von tannat-tabletten, kapseln oder anderen festen dosierformen - Google Patents

Verfahren zur herstellung von tannat-tabletten, kapseln oder anderen festen dosierformen

Info

Publication number
ATE438383T1
ATE438383T1 AT03817708T AT03817708T ATE438383T1 AT E438383 T1 ATE438383 T1 AT E438383T1 AT 03817708 T AT03817708 T AT 03817708T AT 03817708 T AT03817708 T AT 03817708T AT E438383 T1 ATE438383 T1 AT E438383T1
Authority
AT
Austria
Prior art keywords
solid dosage
capsules
producing
dosage forms
tannate
Prior art date
Application number
AT03817708T
Other languages
English (en)
Inventor
Jeffrey S Kiel
Greg H Thomas
Narasimhan Mani
Original Assignee
Kiel Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kiel Lab Inc filed Critical Kiel Lab Inc
Application granted granted Critical
Publication of ATE438383T1 publication Critical patent/ATE438383T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03817708T 2002-10-10 2003-04-09 Verfahren zur herstellung von tannat-tabletten, kapseln oder anderen festen dosierformen ATE438383T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/269,027 US7273623B2 (en) 2001-10-12 2002-10-10 Process for preparing tannate tablet, capsule or other solid dosage forms
PCT/US2003/010918 WO2004032826A2 (en) 2002-10-10 2003-04-09 Process for preparing tannate tablet capsule or other solid dosage forms

Publications (1)

Publication Number Publication Date
ATE438383T1 true ATE438383T1 (de) 2009-08-15

Family

ID=32092418

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03817708T ATE438383T1 (de) 2002-10-10 2003-04-09 Verfahren zur herstellung von tannat-tabletten, kapseln oder anderen festen dosierformen

Country Status (6)

Country Link
US (1) US7273623B2 (de)
EP (1) EP1622586B1 (de)
AT (1) ATE438383T1 (de)
CA (1) CA2482013A1 (de)
DE (1) DE60328722D1 (de)
WO (1) WO2004032826A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8257746B2 (en) 2001-04-10 2012-09-04 Pernix Therapeutics, Llc Tannate compositions, methods of making and methods of use
US7273623B2 (en) * 2001-10-12 2007-09-25 Kiel Laboratories, Inc. Process for preparing tannate tablet, capsule or other solid dosage forms
US8012506B2 (en) * 2001-04-10 2011-09-06 Pernix Therapeutics, Llc Tannate compositions, methods of making and methods of use
US6677381B1 (en) * 2001-12-14 2004-01-13 Jame Fine Chemicals, Inc. Guaifenesin tannate
US7942669B2 (en) 2002-12-02 2011-05-17 Centrix, Inc. Gingival tissue retraction device and method
US6979689B2 (en) * 2002-12-20 2005-12-27 Pediamed Pharmaceuticals, Inc. Compositions and methods for treating upper respiratory congestion
US20040157784A1 (en) * 2003-02-10 2004-08-12 Jame Fine Chemicals, Inc. Opiod tannate compositions
WO2004093827A2 (en) * 2003-03-25 2004-11-04 Kiel Laboratories, Inc. Phenolic acid salts of gabapentin in solid dosage forms and methods of use
WO2004093866A1 (en) * 2003-03-25 2004-11-04 Kiel Laboratories, Inc. Process for preparing phenolic acid salts of gabapentin
WO2004093867A2 (en) * 2003-03-25 2004-11-04 Kiel Laboratories, Inc. Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use
US20050152967A1 (en) * 2003-03-28 2005-07-14 Pfab, Lp Dynamic variable release
JP2007509974A (ja) * 2003-10-31 2007-04-19 アルザ・コーポレーシヨン ３−アミノプロピル−ｎ−ブチルホスフィン酸の増大した吸収のための組成物および薬用量形態
WO2005089721A1 (en) * 2004-03-12 2005-09-29 Kiel Laboratories, Inc. In process conversion method for preparing tannate tablet, capsule or other solid dosage forms
DE102004045037A1 (de) * 2004-09-15 2006-03-16 Basf Ag Pharmazeutische Darreichungsformen mit erschwerter Extrahierbarkeit eines Sympathomimetikums aus der Darreichungsform
US8324641B2 (en) * 2007-06-29 2012-12-04 Ledengin, Inc. Matrix material including an embedded dispersion of beads for a light-emitting device
US20060128637A1 (en) * 2004-12-15 2006-06-15 Kiel Jeffrey S Phenolic acid complexes of hyoscyamine and process for preparing the same
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
US20080118553A1 (en) * 2006-06-12 2008-05-22 Anton Frenkel Tannate salt form of polypeptide mixtures, their preparation and use
US8753613B2 (en) * 2007-03-30 2014-06-17 Centrix, Inc. Dental retraction material having enhanced fluid absorption
WO2009015504A2 (en) 2007-07-30 2009-02-05 Givaudan Sa Mono- or bicyclic carboxylic acids as off-note blockers
US7914828B2 (en) * 2008-10-17 2011-03-29 Levine Brian M Combination herbal product to benefit respiratory tract
CN102596348A (zh) * 2009-04-18 2012-07-18 雷斯特克公司 供固相提取应用的坚实等份的多残留方法用盐
US8361519B2 (en) 2010-11-18 2013-01-29 Aadvantics Pharmaceuticals, Inc. Combination herbal product to benefit respiratory tract in people exposed to smoke
WO2017042835A1 (en) * 2015-09-11 2017-03-16 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical dosage forms of budesonide
CA3120661A1 (en) * 2018-11-21 2020-05-28 Firerein Inc. Fire suppressing pellets

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2950309A (en) * 1955-03-08 1960-08-23 Irwin Neisler And Company Amphetamine tannate
GB894609A (en) 1959-01-20 1962-04-26 Irwin Neisler & Co Tannates of morphine alkaloids
US3197370A (en) * 1961-02-06 1965-07-27 Merck & Co Inc Pyrilamine tannate compositions
US3282789A (en) 1963-05-17 1966-11-01 Neisler Lab Inc Stable liquid colloidal tannate compositions
US3591680A (en) 1969-11-17 1971-07-06 Smith Kline French Lab Concentrated antacid compositions and method of producing antacid activity
US4309989A (en) 1976-02-09 1982-01-12 The Curators Of The University Of Missouri Topical application of medication by ultrasound with coupling agent
US5025019A (en) 1984-04-09 1991-06-18 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4552899A (en) 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4767402A (en) 1986-07-08 1988-08-30 Massachusetts Institute Of Technology Ultrasound enhancement of transdermal drug delivery
US5164398A (en) 1991-04-01 1992-11-17 Merck & Co., Inc. Ibuprofen-antitussive combinations
BR9306816A (pt) 1992-07-28 1998-12-08 Procter & Gamble Composição farmaceutica para uso tópico contendo um polímero catiônico reticulado e um eter alcoxilado
US5773419A (en) 1995-03-03 1998-06-30 Falcon; Juan Method of treating cancer with tannic acid
US6187315B1 (en) 1995-03-03 2001-02-13 Atajje, Inc. Compositions and methods of treating cancer with tannin complexes
US5599846A (en) * 1996-06-28 1997-02-04 Jame Fine Chemicals, Inc. Phenylephrine tannate compositions
US5663415A (en) 1996-06-28 1997-09-02 Jame Fine Chemicals, Inc. Process for preparing antihistamine tannates
US5759579A (en) 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
US6117452A (en) 1998-08-12 2000-09-12 Fuisz Technologies Ltd. Fatty ester combinations
US6287597B1 (en) * 1999-03-12 2001-09-11 Carter-Wallace, Inc. Antihistaminic/decongestant compositions
US6037358A (en) 1999-03-24 2000-03-14 Carter-Wallace, Inc. Decongestant/antihistaminic compositions
US6306904B1 (en) 2000-07-25 2001-10-23 Carter-Wallace, Inc. Antihistaminic/antitussive compositions
US6869618B2 (en) * 2001-04-10 2005-03-22 Kiel Laboratories, Inc. Process for preparing tannate liquid and semi-solid dosage forms
US7273623B2 (en) * 2001-10-12 2007-09-25 Kiel Laboratories, Inc. Process for preparing tannate tablet, capsule or other solid dosage forms
US20030060422A1 (en) * 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
US6455727B1 (en) * 2001-12-14 2002-09-24 Jame Fine Chemicals, Inc. Process for preparing carbetapentane tannate
US20050069584A1 (en) * 2002-04-09 2005-03-31 Kiel Jeffrey S Diphenhydramine tannate solid dose compositions and methods of use

Also Published As

Publication number Publication date
WO2004032826A3 (en) 2004-08-26
CA2482013A1 (en) 2004-04-22
DE60328722D1 (de) 2009-09-17
WO2004032826A2 (en) 2004-04-22
EP1622586A2 (de) 2006-02-08
US7273623B2 (en) 2007-09-25
US20030077321A1 (en) 2003-04-24
EP1622586B1 (de) 2009-08-05
WO2004032826A8 (en) 2005-02-10
EP1622586A4 (de) 2007-03-21

Similar Documents

Publication Publication Date Title
DE60328722D1 (de) Verfahren zur herstellung von tannat-tabletten, kapseln oder anderen festen dosierformen
GB0211649D0 (en) Organic compounds
TWI265812B (en) Pharmaceutical safety dosage forms
CY1112510T1 (el) Φαρμακευτικο παρασκευασμα υπο τη μορφη παστας το οποιο περιεχει ενα ασταθες στα οξεα δραστικο συστατικο
SE0100568D0 (sv) Compounds
EA200901146A1 (ru) Твердые лекарственные формы, содержащие алискирен и его фармацевтически приемлемые соли
RU2012157328A (ru) Лекарственное средство для профилактического и/или терапевтического лечения деменции по типу альцгеймера
RU2008122964A (ru) Азитромицин для лечения гранулематозных розовых (красных) угрей
SE0100566D0 (sv) Compounds
ATE502637T1 (de) Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum
EE200200549A (et) Jagatud doosi teraapia veresooni kahjustava aktiivsusega
DK1530459T3 (da) Oral farmaceutisk sammensætning til bløde kapsler indeholdende vinorelbin samt fremgangsmåde til behandling
NO20045657L (no) Fremgangsmate ved fremstilling av fast doseringsform for desmopressin
TW200505427A (en) A solid oral dosage form of metformin and glyburide and the method of preparation thereof
RU2010122438A (ru) Противовирусное средство для профилактики и лечения клещевого энцефалита
Kharb Hypertension: case report
RU2002122703A (ru) Способ лечения воспалительных и воспалительно-деструктивных заболеваний пародонта
GEP20043356B (en) Compounds Useful For Treatment or Prevention of Diseases Mediated By Alpha- 2B-Adrenoceptor
TH60587A (th) องค์ประกอบทางเภสัชกรรมซึ่งประกอบรวมด้วยกรดมายโคฟีนอลิก หรือ เกลือมายโคฟีนอเลต
RU2002123989A (ru) Способ лечения хронических заболеваний печени с проявлениями нарушений микроэкологии кишечника
RU2011125992A (ru) Лекарственное средство для лечения патологического синдрома и способ лечения острых и хронических заболеваний дыхательной системы и синдрома кашля
RU2004119923A (ru) Способ лечения туберкулеза
RU2009123832A (ru) Способ и фармацевтическая композиция для лечения и профилактики вирусного лейкоза крупного рогатого скота
RU2002134891A (ru) Лекарственное средство и способ лечения генитального остроконечного кондиломатоза
RU2004121098A (ru) Способ лечения угревой болезни

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties